gut-health

Probiotic Heart Marker Evidence Rated Low in Review

A Frontiers in Microbiology review of six trials in 296 coronary heart disease patients found glucose and HDL changes, but graded the evidence low certainty

Scientist working at a laboratory bench

A systematic review published in Frontiers in Microbiology on 23 October 2026 pooled six randomised controlled trials of probiotics or synbiotic supplements given to people already diagnosed with coronary heart disease, and rated its own strongest findings as low certainty evidence. The six trials covered 296 participants between them. Across the four trials that measured it, fasting blood glucose was 19.25 mg/dL lower in the supplement groups than in the comparison groups (95% confidence interval -32.28 to -6.22), and HDL cholesterol was 3.70 mg/dL higher (95% CI 1.65 to 5.74). LDL cholesterol, total cholesterol, triglycerides, insulin and both systolic and diastolic blood pressure showed no significant difference. The authors, at Hunan University of Chinese Medicine and its first affiliated hospital, graded the certainty of the glucose and HDL findings as low, and the LDL finding as very low. No trial in the review measured heart attacks, strokes or deaths.

Why the Authors Call the Evidence Weak

Five of the six trials were run in Iran and one in China, which the review says limits how far the results carry to populations with different diets, microbiome profiles, ethnic backgrounds or healthcare systems. The trials also used different strains, formulations, doses and durations. A trial sequential analysis, which tests whether enough data has accumulated for a pooled result to be trusted, did not reach the required information size for either the glucose or the HDL finding. Adverse event rates did not differ significantly between groups, although the authors noted that few events were reported and the confidence intervals were wide. Funding came from provincial research bodies in Hunan, and the authors declared no commercial or financial conflicts of interest.

What This Means for Your Supplement Routine

Nothing in this review was measured in healthy adults. Every participant had an existing diagnosis and was under medical care, so the figures describe that group rather than the general population. The review also stops at blood markers, and did not follow anyone long enough to see whether a change in those markers made any difference to cardiac events. For anyone who already buys probiotics, the trial base under them remains small, and a statistically significant pooled figure can still rest on evidence the authors themselves grade as low. Strain, dose and duration varied most between these six trials, and they vary just as widely between products on sale, which is part of why a pooled result is hard to read across to any single one of them.

How Perqen Members Save

Membership costs £4.99 a month or £29.99 a year and unlocks member pricing across all 1,393 products, while non-members pay standard prices. The pricing is set out on the Perqen membership page, and the mechanics of how member pricing works are in the FAQs.

This article reports published news and research and is for information only. Food supplements are not a substitute for a varied diet or medical care, and no product mentioned is intended to diagnose, treat, cure or prevent any disease. Speak to your GP or pharmacist before changing what you take, especially if you are pregnant, breastfeeding, or taking prescribed medicines.

Sources